Status:
COMPLETED
7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Ventilator Associated Pneumonia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
There is evidence that using shorter antibiotic regimens may help in decreasing antimicrobial resistance and reducing drug-related adverse events.6 Moreover, short-course treatments were found to be a...
Detailed Description
Ventilator-associated pneumonia (VAP) is one of the major causes of morbidity and mortality in the ICU, accounting for 25% of the total infections occurring in this setting and 50% of all antibiotic p...
Eligibility Criteria
Inclusion
- (a) Patients who develop ventilator associated pneumonia due to drug-resistant Acinetobacter baumanii; (b) age group of 18 to 75 years
Exclusion
- (a) VAP due to other organisms; (b) pregnancy; (c) endotracheal or tracheostomy tube aspirate demonstrating growth of drug sensitive Acinetobacter baumanii or an organism other than Acinetobacter baumanii; and, (c) failure to provide informed consent.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03477292
Start Date
March 1 2018
End Date
December 31 2024
Last Update
December 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory ICU, Department of Pulmonary Medicine, PGIMER
Chandigarh, Chandigarh, India, 160012
2
Respiratory ICU, Post Graduate Institue of Medical Education and Research
Chandigarh, Chandigarh, India, 160012